Copyright Reports & Markets. All rights reserved.

Global Circulating Tumor Cells Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Circulating Tumor Cells Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Circulating Tumor Cells Market Size Growth Rate by Product
      • 1.4.2 CTC Enrichment
      • 1.4.3 CTC Detection
      • 1.4.4 CTC Analysis
    • 1.5 Market by End User
      • 1.5.1 Global Circulating Tumor Cells Market Size Growth Rate by End User
      • 1.5.2 Prostate Cancer
      • 1.5.3 Breast Cancer
      • 1.5.4 Colorectal Cancer
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Circulating Tumor Cells Market Size
      • 2.1.1 Global Circulating Tumor Cells Revenue 2014-2025
      • 2.1.2 Global Circulating Tumor Cells Sales 2014-2025
    • 2.2 Circulating Tumor Cells Growth Rate by Regions
      • 2.2.1 Global Circulating Tumor Cells Sales by Regions
      • 2.2.2 Global Circulating Tumor Cells Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Circulating Tumor Cells Sales by Manufacturers
      • 3.1.1 Circulating Tumor Cells Sales by Manufacturers
      • 3.1.2 Circulating Tumor Cells Sales Market Share by Manufacturers
      • 3.1.3 Global Circulating Tumor Cells Market Concentration Ratio (CR5 and HHI)
    • 3.2 Circulating Tumor Cells Revenue by Manufacturers
      • 3.2.1 Circulating Tumor Cells Revenue by Manufacturers (2014-2019)
      • 3.2.2 Circulating Tumor Cells Revenue Share by Manufacturers (2014-2019)
    • 3.3 Circulating Tumor Cells Price by Manufacturers
    • 3.4 Circulating Tumor Cells Manufacturing Base Distribution, Product Types
      • 3.4.1 Circulating Tumor Cells Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Circulating Tumor Cells Product Type
      • 3.4.3 Date of International Manufacturers Enter into Circulating Tumor Cells Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Circulating Tumor Cells Sales by Product
    • 4.2 Global Circulating Tumor Cells Revenue by Product
    • 4.3 Circulating Tumor Cells Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Circulating Tumor Cells Breakdown Data by End User

    6 North America

    • 6.1 North America Circulating Tumor Cells by Countries
      • 6.1.1 North America Circulating Tumor Cells Sales by Countries
      • 6.1.2 North America Circulating Tumor Cells Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Circulating Tumor Cells by Product
    • 6.3 North America Circulating Tumor Cells by End User

    7 Europe

    • 7.1 Europe Circulating Tumor Cells by Countries
      • 7.1.1 Europe Circulating Tumor Cells Sales by Countries
      • 7.1.2 Europe Circulating Tumor Cells Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Circulating Tumor Cells by Product
    • 7.3 Europe Circulating Tumor Cells by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Circulating Tumor Cells by Countries
      • 8.1.1 Asia Pacific Circulating Tumor Cells Sales by Countries
      • 8.1.2 Asia Pacific Circulating Tumor Cells Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Circulating Tumor Cells by Product
    • 8.3 Asia Pacific Circulating Tumor Cells by End User

    9 Central & South America

    • 9.1 Central & South America Circulating Tumor Cells by Countries
      • 9.1.1 Central & South America Circulating Tumor Cells Sales by Countries
      • 9.1.2 Central & South America Circulating Tumor Cells Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Circulating Tumor Cells by Product
    • 9.3 Central & South America Circulating Tumor Cells by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Circulating Tumor Cells by Countries
      • 10.1.1 Middle East and Africa Circulating Tumor Cells Sales by Countries
      • 10.1.2 Middle East and Africa Circulating Tumor Cells Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Circulating Tumor Cells by Product
    • 10.3 Middle East and Africa Circulating Tumor Cells by End User

    11 Company Profiles

    • 11.1 Janssen
      • 11.1.1 Janssen Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Janssen Circulating Tumor Cells Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Janssen Circulating Tumor Cells Products Offered
      • 11.1.5 Janssen Recent Development
    • 11.2 Qiagen（Adnagen）
      • 11.2.1 Qiagen（Adnagen） Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Qiagen（Adnagen） Circulating Tumor Cells Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Qiagen（Adnagen） Circulating Tumor Cells Products Offered
      • 11.2.5 Qiagen（Adnagen） Recent Development
    • 11.3 Acousys Biodevices
      • 11.3.1 Acousys Biodevices Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Acousys Biodevices Circulating Tumor Cells Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Acousys Biodevices Circulating Tumor Cells Products Offered
      • 11.3.5 Acousys Biodevices Recent Development
    • 11.4 ApoCell
      • 11.4.1 ApoCell Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 ApoCell Circulating Tumor Cells Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 ApoCell Circulating Tumor Cells Products Offered
      • 11.4.5 ApoCell Recent Development
    • 11.5 Advanced Cell Diagnostics
      • 11.5.1 Advanced Cell Diagnostics Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Advanced Cell Diagnostics Circulating Tumor Cells Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Advanced Cell Diagnostics Circulating Tumor Cells Products Offered
      • 11.5.5 Advanced Cell Diagnostics Recent Development
    • 11.6 Fluxion Biosciences
      • 11.6.1 Fluxion Biosciences Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Fluxion Biosciences Circulating Tumor Cells Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Fluxion Biosciences Circulating Tumor Cells Products Offered
      • 11.6.5 Fluxion Biosciences Recent Development
    • 11.7 Biocept
      • 11.7.1 Biocept Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Biocept Circulating Tumor Cells Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Biocept Circulating Tumor Cells Products Offered
      • 11.7.5 Biocept Recent Development
    • 11.8 Fluidigm
      • 11.8.1 Fluidigm Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Fluidigm Circulating Tumor Cells Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Fluidigm Circulating Tumor Cells Products Offered
      • 11.8.5 Fluidigm Recent Development
    • 11.9 Epic Sciences
      • 11.9.1 Epic Sciences Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Epic Sciences Circulating Tumor Cells Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Epic Sciences Circulating Tumor Cells Products Offered
      • 11.9.5 Epic Sciences Recent Development
    • 11.10 Clearbridge Biomedics
      • 11.10.1 Clearbridge Biomedics Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Clearbridge Biomedics Circulating Tumor Cells Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Clearbridge Biomedics Circulating Tumor Cells Products Offered
      • 11.10.5 Clearbridge Biomedics Recent Development
    • 11.11 Cynvenio
    • 11.12 CytoTrack
    • 11.13 ScreenCell
    • 11.14 Creatv Microtech
    • 11.15 Aviva Biosciences
    • 11.16 Greiner Bio-one
    • 11.17 Sysmex
    • 11.18 Ikonisys

    12 Future Forecast

    • 12.1 Circulating Tumor Cells Market Forecast by Regions
      • 12.1.1 Global Circulating Tumor Cells Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Circulating Tumor Cells Revenue Forecast by Regions 2019-2025
    • 12.2 Circulating Tumor Cells Market Forecast by Product
      • 12.2.1 Global Circulating Tumor Cells Sales Forecast by Product 2019-2025
      • 12.2.2 Global Circulating Tumor Cells Revenue Forecast by Product 2019-2025
    • 12.3 Circulating Tumor Cells Market Forecast by End User
    • 12.4 North America Circulating Tumor Cells Forecast
    • 12.5 Europe Circulating Tumor Cells Forecast
    • 12.6 Asia Pacific Circulating Tumor Cells Forecast
    • 12.7 Central & South America Circulating Tumor Cells Forecast
    • 12.8 Middle East and Africa Circulating Tumor Cells Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Circulating Tumor Cells Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Circulating Tumor Cells market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Circulating Tumor Cells market based on company, product type, end user and key regions.

      This report studies the global market size of Circulating Tumor Cells in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Circulating Tumor Cells in these regions.
      This research report categorizes the global Circulating Tumor Cells market by top players/brands, region, type and end user. This report also studies the global Circulating Tumor Cells market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Janssen
      Qiagen（Adnagen）
      Acousys Biodevices
      ApoCell
      Advanced Cell Diagnostics
      Fluxion Biosciences
      Biocept
      Fluidigm
      Epic Sciences
      Clearbridge Biomedics
      Cynvenio
      CytoTrack
      ScreenCell
      Creatv Microtech
      Aviva Biosciences
      Greiner Bio-one
      Sysmex
      Ikonisys

      Market size by Product
      CTC Enrichment
      CTC Detection
      CTC Analysis
      Market size by End User
      Prostate Cancer
      Breast Cancer
      Colorectal Cancer
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Circulating Tumor Cells market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Circulating Tumor Cells market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Circulating Tumor Cells companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Circulating Tumor Cells submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Circulating Tumor Cells are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Circulating Tumor Cells market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now